| 0 |
INJURY OF CONJUNCTIVA |
1 |
0.1429 |
| 1 |
DIAPEDESIS |
2 |
0.1176 |
| 2 |
PERIORBITAL FAT HERNIATION |
2 |
0.1176 |
| 3 |
AQUEOUS FIBRIN |
3 |
0.0588 |
| 4 |
TRANSURETHRAL RESECTION SYNDROME |
1 |
0.0400 |
| 5 |
CORNEAL EPITHELIUM DEFECT |
22 |
0.0379 |
| 6 |
RETINAL PIGMENT EPITHELIUM CHANGE |
1 |
0.0345 |
| 7 |
EXPOSURE VIA MUCOSA |
2 |
0.0333 |
| 8 |
CHORIORETINAL FOLDS |
2 |
0.0282 |
| 9 |
THYROID STIMULATING IMMUNOGLOBULIN INCREASED |
2 |
0.0250 |
| 10 |
KERATOPLASTY |
1 |
0.0238 |
| 11 |
CIRCUMORAL SWELLING |
3 |
0.0234 |
| 12 |
BACTERIAL ENDOPHTHALMITIS |
6 |
0.0226 |
| 13 |
CORNEAL INFILTRATES |
7 |
0.0223 |
| 14 |
NASAL VALVE COLLAPSE |
1 |
0.0204 |
| 15 |
TOXIC ANTERIOR SEGMENT SYNDROME |
20 |
0.0183 |
| 16 |
RETINAL DRUSEN |
3 |
0.0183 |
| 17 |
CORNEAL TOXICITY |
2 |
0.0180 |
| 18 |
HYPOPYON |
13 |
0.0157 |
| 19 |
CONJUNCTIVAL ULCER |
2 |
0.0145 |
| 20 |
HARLEQUIN SYNDROME |
1 |
0.0137 |
| 21 |
DERMATOCHALASIS |
2 |
0.0136 |
| 22 |
PERIPHLEBITIS |
1 |
0.0135 |
| 23 |
AUTOPHONY |
1 |
0.0133 |
| 24 |
SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT |
16 |
0.0129 |
| 25 |
POSTERIOR CAPSULE RUPTURE |
1 |
0.0127 |
| 26 |
PAPILLARY CYSTADENOMA LYMPHOMATOSUM |
1 |
0.0127 |
| 27 |
RETINAL CYST |
2 |
0.0120 |
| 28 |
MACULAR PIGMENTATION |
1 |
0.0119 |
| 29 |
OPHTHALMOLOGICAL EXAMINATION ABNORMAL |
2 |
0.0113 |
| 30 |
DEAFNESS PERMANENT |
2 |
0.0102 |
| 31 |
PSEUDOENDOPHTHALMITIS |
1 |
0.0101 |
| 32 |
PHARYNGEAL STENOSIS |
1 |
0.0097 |
| 33 |
PINGUECULA |
1 |
0.0094 |
| 34 |
CATARACT NUCLEAR |
6 |
0.0090 |
| 35 |
UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE |
1 |
0.0084 |
| 36 |
IRIS NEOVASCULARISATION |
1 |
0.0080 |
| 37 |
ANTI-THYROID ANTIBODY INCREASED |
1 |
0.0079 |
| 38 |
ANTERIOR CHAMBER FIBRIN |
1 |
0.0078 |
| 39 |
NEOVASCULARISATION |
2 |
0.0076 |
| 40 |
RETINOSCHISIS |
1 |
0.0072 |
| 41 |
MYOCARDIAL STRAIN |
1 |
0.0072 |
| 42 |
PH BODY FLUID ABNORMAL |
1 |
0.0072 |
| 43 |
SUPRAVENTRICULAR TACHYARRHYTHMIA |
1 |
0.0071 |
| 44 |
RETINOPATHY HYPERTENSIVE |
2 |
0.0066 |
| 45 |
VITREOUS HAZE |
1 |
0.0065 |
| 46 |
CORNEAL LESION |
2 |
0.0065 |
| 47 |
CORNEAL DECOMPENSATION |
1 |
0.0062 |
| 48 |
VITREOUS DEGENERATION |
1 |
0.0061 |
| 49 |
CORNEAL SCAR |
3 |
0.0060 |
| 50 |
DIABETIC RETINAL OEDEMA |
3 |
0.0059 |
| 51 |
POSTERIOR CAPSULE OPACIFICATION |
2 |
0.0058 |
| 52 |
SUBRETINAL FLUID |
6 |
0.0055 |
| 53 |
ENDOPHTHALMITIS |
32 |
0.0053 |
| 54 |
SUBRETINAL FIBROSIS |
1 |
0.0051 |
| 55 |
CORNEAL OPACITY |
7 |
0.0051 |
| 56 |
EYELID SENSORY DISORDER |
1 |
0.0051 |
| 57 |
CARDIAC NEOPLASM UNSPECIFIED |
1 |
0.0050 |
| 58 |
RETINAL TOXICITY |
5 |
0.0049 |
| 59 |
VENTRICULAR DYSKINESIA |
1 |
0.0048 |
| 60 |
LENS DISLOCATION |
1 |
0.0048 |
| 61 |
ENDOCRINE OPHTHALMOPATHY |
4 |
0.0046 |
| 62 |
SINUS ARRHYTHMIA |
6 |
0.0046 |
| 63 |
HYPERINSULINAEMIC HYPOGLYCAEMIA |
1 |
0.0045 |
| 64 |
VERY LOW DENSITY LIPOPROTEIN INCREASED |
1 |
0.0045 |
| 65 |
MACULAR FIBROSIS |
3 |
0.0044 |
| 66 |
PUNCTATE KERATITIS |
4 |
0.0044 |
| 67 |
ANTERIOR CHAMBER DISORDER |
1 |
0.0043 |
| 68 |
HYPOGONADISM MALE |
1 |
0.0043 |
| 69 |
ANTERIOR CHAMBER CELL |
3 |
0.0042 |
| 70 |
VITREOUS DETACHMENT |
9 |
0.0041 |
| 71 |
CORNEAL NEOVASCULARISATION |
1 |
0.0040 |
| 72 |
INTRAOCULAR LENS IMPLANT |
2 |
0.0040 |
| 73 |
CORNEAL OEDEMA |
9 |
0.0040 |
| 74 |
RETINAL NEOVASCULARISATION |
1 |
0.0040 |
| 75 |
GLARE |
2 |
0.0039 |
| 76 |
APNOEA NEONATAL |
1 |
0.0039 |
| 77 |
HYPHAEMA |
2 |
0.0038 |
| 78 |
CUTIS LAXA |
1 |
0.0037 |
| 79 |
EYE OEDEMA |
9 |
0.0037 |
| 80 |
PRODUCT INFORMATION CONTENT COMPLAINT |
1 |
0.0036 |
| 81 |
CHOROIDAL NEOVASCULARISATION |
3 |
0.0035 |
| 82 |
DETACHMENT OF RETINAL PIGMENT EPITHELIUM |
3 |
0.0034 |
| 83 |
ANTERIOR CHAMBER INFLAMMATION |
2 |
0.0034 |
| 84 |
RETINAL DEPIGMENTATION |
1 |
0.0033 |
| 85 |
NEPHRITIC SYNDROME |
1 |
0.0032 |
| 86 |
RETINAL EXUDATES |
3 |
0.0032 |
| 87 |
EXTRAOCULAR MUSCLE DISORDER |
1 |
0.0031 |
| 88 |
APPLICATION SITE OEDEMA |
1 |
0.0031 |
| 89 |
PULMONARY ARTERY DILATATION |
1 |
0.0029 |
| 90 |
TACHYPHYLAXIS |
1 |
0.0029 |
| 91 |
MUSCLE HYPERTROPHY |
1 |
0.0028 |
| 92 |
COLOUR BLINDNESS ACQUIRED |
1 |
0.0028 |
| 93 |
ELECTROCARDIOGRAM T WAVE INVERSION |
6 |
0.0027 |
| 94 |
NASAL TURBINATE HYPERTROPHY |
1 |
0.0027 |
| 95 |
CORNEAL DYSTROPHY |
1 |
0.0024 |
| 96 |
MANTLE CELL LYMPHOMA RECURRENT |
1 |
0.0023 |
| 97 |
CORNEAL ABRASION |
3 |
0.0022 |
| 98 |
RETINAL SCAR |
1 |
0.0022 |
| 99 |
METAMORPHOPSIA |
4 |
0.0022 |
| 100 |
VITRITIS |
4 |
0.0022 |
| 101 |
RETINAL OEDEMA |
4 |
0.0021 |
| 102 |
FOREIGN BODY IN EYE |
2 |
0.0021 |
| 103 |
TYPE V HYPERLIPIDAEMIA |
1 |
0.0021 |
| 104 |
PO2 INCREASED |
1 |
0.0020 |
| 105 |
IRIS ADHESIONS |
1 |
0.0019 |
| 106 |
CORNEAL EROSION |
1 |
0.0019 |
| 107 |
BODY FAT DISORDER |
1 |
0.0018 |
| 108 |
PRESBYOPIA |
1 |
0.0018 |
| 109 |
BACTERIAL TEST POSITIVE |
4 |
0.0018 |
| 110 |
ECZEMA EYELIDS |
1 |
0.0018 |
| 111 |
BONE FRAGMENTATION |
1 |
0.0018 |
| 112 |
NAIL BED BLEEDING |
1 |
0.0018 |
| 113 |
EMBOLISM ARTERIAL |
2 |
0.0017 |
| 114 |
PUPILLARY DISORDER |
1 |
0.0016 |
| 115 |
CATARACT SUBCAPSULAR |
1 |
0.0016 |
| 116 |
PUPILLARY REFLEX IMPAIRED |
3 |
0.0016 |
| 117 |
DERMATOSIS |
1 |
0.0016 |
| 118 |
CYSTOID MACULAR OEDEMA |
3 |
0.0016 |
| 119 |
VASODILATATION |
4 |
0.0016 |
| 120 |
CHALAZION |
1 |
0.0016 |
| 121 |
CHORIORETINITIS |
1 |
0.0016 |
| 122 |
RETINAL DEGENERATION |
2 |
0.0015 |
| 123 |
COMPUTERISED TOMOGRAM THORAX ABNORMAL |
1 |
0.0015 |
| 124 |
EYE INFLAMMATION |
13 |
0.0014 |
| 125 |
ASTIGMATISM |
2 |
0.0013 |
| 126 |
RETINAL INJURY |
1 |
0.0013 |
| 127 |
ROSACEA |
6 |
0.0013 |
| 128 |
IRIDOCYCLITIS |
4 |
0.0013 |
| 129 |
WOUND DRAINAGE |
1 |
0.0013 |
| 130 |
SINUSITIS FUNGAL |
1 |
0.0012 |
| 131 |
OCULAR VASCULAR DISORDER |
1 |
0.0012 |
| 132 |
NEONATAL HYPOXIA |
1 |
0.0012 |
| 133 |
SEROUS RETINAL DETACHMENT |
1 |
0.0012 |
| 134 |
VITREOUS OPACITIES |
1 |
0.0012 |
| 135 |
NON-INFECTIOUS ENDOPHTHALMITIS |
1 |
0.0012 |
| 136 |
MALIGNANT HYPERTENSION |
1 |
0.0012 |
| 137 |
OPTICAL COHERENCE TOMOGRAPHY ABNORMAL |
1 |
0.0012 |
| 138 |
RETINAL DISORDER |
3 |
0.0012 |
| 139 |
VITREOUS FLOATERS |
11 |
0.0011 |
| 140 |
BLOOD SODIUM INCREASED |
3 |
0.0011 |
| 141 |
CERUMEN IMPACTION |
1 |
0.0011 |
| 142 |
VITREOUS HAEMORRHAGE |
3 |
0.0011 |
| 143 |
VENOUS INJURY |
1 |
0.0011 |
| 144 |
STRESS CARDIOMYOPATHY |
6 |
0.0010 |
| 145 |
BRAIN HYPOXIA |
1 |
0.0010 |
| 146 |
INJECTION SITE NECROSIS |
2 |
0.0010 |
| 147 |
CONJUNCTIVAL OEDEMA |
1 |
0.0010 |
| 148 |
PHOTOPSIA |
6 |
0.0009 |
| 149 |
CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER |
1 |
0.0009 |
| 150 |
LOCAL ANAESTHETIC SYSTEMIC TOXICITY |
1 |
0.0009 |
| 151 |
ELECTROCARDIOGRAM ST SEGMENT DEPRESSION |
2 |
0.0009 |
| 152 |
DRY AGE-RELATED MACULAR DEGENERATION |
1 |
0.0009 |
| 153 |
ARTERIAL HAEMORRHAGE |
1 |
0.0009 |
| 154 |
WOUND COMPLICATION |
3 |
0.0009 |
| 155 |
ALLODYNIA |
1 |
0.0009 |
| 156 |
DEVICE DISPENSING ERROR |
1 |
0.0008 |
| 157 |
PRODUCT CONTAMINATION MICROBIAL |
1 |
0.0008 |
| 158 |
RETINAL TEAR |
2 |
0.0008 |
| 159 |
NOCTURNAL DYSPNOEA |
1 |
0.0008 |
| 160 |
STENOTROPHOMONAS INFECTION |
1 |
0.0007 |
| 161 |
ULCERATIVE KERATITIS |
2 |
0.0007 |
| 162 |
NEOVASCULAR AGE-RELATED MACULAR DEGENERATION |
1 |
0.0007 |
| 163 |
PERIODONTAL DISEASE |
1 |
0.0007 |
| 164 |
MAST CELL ACTIVATION SYNDROME |
1 |
0.0007 |
| 165 |
AUDITORY DISORDER |
1 |
0.0007 |
| 166 |
DERMATITIS CONTACT |
8 |
0.0007 |
| 167 |
COMPLEX REGIONAL PAIN SYNDROME |
1 |
0.0007 |
| 168 |
EYE INJURY |
2 |
0.0007 |
| 169 |
KERATITIS |
2 |
0.0007 |
| 170 |
MEAN CELL VOLUME DECREASED |
1 |
0.0006 |
| 171 |
RESPIRATORY RATE DECREASED |
2 |
0.0006 |
| 172 |
FUNGAEMIA |
1 |
0.0006 |
| 173 |
DEAFNESS NEUROSENSORY |
2 |
0.0006 |
| 174 |
BLOOD PH DECREASED |
1 |
0.0006 |
| 175 |
ANAPHYLACTIC SHOCK |
15 |
0.0006 |
| 176 |
RETINITIS |
1 |
0.0006 |
| 177 |
MUSCLE CONTRACTIONS INVOLUNTARY |
2 |
0.0006 |
| 178 |
TYPE I HYPERSENSITIVITY |
2 |
0.0006 |
| 179 |
FACIAL PARESIS |
2 |
0.0006 |
| 180 |
TETANY |
1 |
0.0005 |
| 181 |
EYE DISORDER |
18 |
0.0005 |
| 182 |
BLINDNESS TRANSIENT |
4 |
0.0005 |
| 183 |
VISUAL ACUITY REDUCED |
18 |
0.0005 |
| 184 |
OPPORTUNISTIC INFECTION |
1 |
0.0005 |
| 185 |
MACULAR OEDEMA |
3 |
0.0005 |
| 186 |
LIP DISORDER |
1 |
0.0005 |
| 187 |
CONJUNCTIVAL HAEMORRHAGE |
2 |
0.0005 |
| 188 |
THYROID MASS |
2 |
0.0005 |
| 189 |
OCULAR HYPERTENSION |
1 |
0.0005 |
| 190 |
ATROPHY |
1 |
0.0005 |
| 191 |
NASAL SEPTUM DEVIATION |
1 |
0.0005 |
| 192 |
SUSPECTED COUNTERFEIT PRODUCT |
2 |
0.0005 |
| 193 |
AZOTAEMIA |
2 |
0.0005 |
| 194 |
PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION |
3 |
0.0005 |
| 195 |
PHOTOPHOBIA |
9 |
0.0005 |
| 196 |
OPTIC NEUROPATHY |
1 |
0.0005 |
| 197 |
FOREIGN BODY SENSATION IN EYES |
3 |
0.0005 |
| 198 |
INFLAMMATION |
24 |
0.0005 |
| 199 |
GRAFT VERSUS HOST DISEASE IN SKIN |
1 |
0.0005 |
| 200 |
CLOSTRIDIUM TEST POSITIVE |
1 |
0.0005 |
| 201 |
RETINAL DETACHMENT |
4 |
0.0004 |
| 202 |
EYE OPERATION |
2 |
0.0004 |
| 203 |
APHTHOUS STOMATITIS |
1 |
0.0004 |
| 204 |
METHAEMOGLOBINAEMIA |
1 |
0.0004 |
| 205 |
HYPERTRANSAMINASAEMIA |
3 |
0.0004 |
| 206 |
SINUS PAIN |
1 |
0.0004 |
| 207 |
BLINDNESS UNILATERAL |
6 |
0.0004 |
| 208 |
RETINAL HAEMORRHAGE |
3 |
0.0004 |
| 209 |
SLOW SPEECH |
1 |
0.0004 |
| 210 |
JUVENILE IDIOPATHIC ARTHRITIS |
1 |
0.0004 |
| 211 |
DERMATITIS EXFOLIATIVE |
2 |
0.0004 |
| 212 |
INTRAOCULAR PRESSURE INCREASED |
5 |
0.0004 |
| 213 |
EYE DISCHARGE |
4 |
0.0004 |
| 214 |
LARYNGOSPASM |
1 |
0.0004 |
| 215 |
EAR CONGESTION |
1 |
0.0004 |
| 216 |
SKIN WRINKLING |
1 |
0.0004 |
| 217 |
SUBDURAL HAEMORRHAGE |
1 |
0.0004 |
| 218 |
LUNG CONSOLIDATION |
1 |
0.0004 |
| 219 |
ENDOTRACHEAL INTUBATION |
1 |
0.0004 |
| 220 |
NEUTROPHIL COUNT ABNORMAL |
1 |
0.0004 |
| 221 |
EYELID MARGIN CRUSTING |
1 |
0.0003 |
| 222 |
STRABISMUS |
1 |
0.0003 |
| 223 |
EYE PAIN |
19 |
0.0003 |
| 224 |
SQUAMOUS CELL CARCINOMA OF SKIN |
2 |
0.0003 |
| 225 |
BONE MARROW DISORDER |
1 |
0.0003 |
| 226 |
IRITIS |
1 |
0.0003 |
| 227 |
PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
2 |
0.0003 |
| 228 |
DRUG EFFECT INCREASED |
1 |
0.0003 |
| 229 |
OCULAR HYPERAEMIA |
15 |
0.0003 |
| 230 |
BLADDER PAIN |
1 |
0.0003 |
| 231 |
POSTURE ABNORMAL |
1 |
0.0003 |
| 232 |
HIGH DENSITY LIPOPROTEIN DECREASED |
1 |
0.0003 |
| 233 |
EYE HAEMORRHAGE |
4 |
0.0003 |
| 234 |
DIABETIC RETINOPATHY |
1 |
0.0003 |
| 235 |
DEFAECATION URGENCY |
2 |
0.0003 |
| 236 |
NEUROTOXICITY |
5 |
0.0003 |
| 237 |
CONJUNCTIVAL HYPERAEMIA |
1 |
0.0003 |
| 238 |
EYE IRRITATION |
16 |
0.0003 |
| 239 |
RENAL TRANSPLANT |
1 |
0.0003 |
| 240 |
VISUAL FIELD DEFECT |
2 |
0.0003 |
| 241 |
BLINDNESS |
11 |
0.0003 |
| 242 |
CARDIAC DYSFUNCTION |
1 |
0.0003 |
| 243 |
RETINOPATHY |
1 |
0.0003 |
| 244 |
OCULAR DISCOMFORT |
3 |
0.0003 |
| 245 |
CHRONIC SINUSITIS |
1 |
0.0003 |
| 246 |
SNORING |
1 |
0.0003 |
| 247 |
AUTOIMMUNE THYROIDITIS |
1 |
0.0003 |
| 248 |
PARANASAL SINUS DISCOMFORT |
1 |
0.0003 |
| 249 |
POST PROCEDURAL COMPLICATION |
5 |
0.0003 |
| 250 |
APNOEA |
2 |
0.0003 |
| 251 |
THROAT CANCER |
1 |
0.0002 |
| 252 |
VITAMIN D DECREASED |
2 |
0.0002 |
| 253 |
ABNORMAL SENSATION IN EYE |
1 |
0.0002 |
| 254 |
DIPLOPIA |
6 |
0.0002 |
| 255 |
MONOPLEGIA |
1 |
0.0002 |
| 256 |
DIVERTICULUM INTESTINAL |
1 |
0.0002 |
| 257 |
DYSPHEMIA |
1 |
0.0002 |
| 258 |
LIGAMENT RUPTURE |
1 |
0.0002 |
| 259 |
CYTOMEGALOVIRUS VIRAEMIA |
1 |
0.0002 |
| 260 |
DRUG TOXICITY |
3 |
0.0002 |
| 261 |
BLOOD THYROID STIMULATING HORMONE DECREASED |
1 |
0.0002 |
| 262 |
BLOOD PRESSURE SYSTOLIC DECREASED |
1 |
0.0002 |
| 263 |
PATHOGEN RESISTANCE |
2 |
0.0002 |
| 264 |
BUNDLE BRANCH BLOCK RIGHT |
1 |
0.0002 |
| 265 |
BLOOD THYROID STIMULATING HORMONE INCREASED |
2 |
0.0002 |
| 266 |
NEPHROGENIC ANAEMIA |
1 |
0.0002 |
| 267 |
CONJUNCTIVITIS |
4 |
0.0002 |
| 268 |
SKIN TIGHTNESS |
1 |
0.0002 |
| 269 |
ATELECTASIS |
2 |
0.0002 |
| 270 |
BRAIN INJURY |
2 |
0.0002 |
| 271 |
ERYSIPELAS |
1 |
0.0002 |
| 272 |
CORONARY ARTERY STENOSIS |
1 |
0.0002 |
| 273 |
CORONARY ARTERIAL STENT INSERTION |
1 |
0.0002 |
| 274 |
BENIGN PROSTATIC HYPERPLASIA |
1 |
0.0002 |
| 275 |
VENTRICULAR EXTRASYSTOLES |
2 |
0.0002 |
| 276 |
TONSILLITIS |
1 |
0.0002 |
| 277 |
DERMATITIS |
4 |
0.0002 |
| 278 |
NYSTAGMUS |
1 |
0.0002 |
| 279 |
OVERWEIGHT |
1 |
0.0002 |
| 280 |
ERYTHEMA OF EYELID |
1 |
0.0002 |
| 281 |
NORMAL NEWBORN |
1 |
0.0002 |
| 282 |
VISION BLURRED |
25 |
0.0002 |
| 283 |
MENTAL STATUS CHANGES |
5 |
0.0002 |
| 284 |
ANGIOPATHY |
1 |
0.0002 |
| 285 |
PERIORBITAL SWELLING |
1 |
0.0002 |
| 286 |
CORONARY ARTERY BYPASS |
1 |
0.0002 |
| 287 |
MOUTH SWELLING |
1 |
0.0002 |
| 288 |
HYPERVENTILATION |
1 |
0.0002 |
| 289 |
DYSKINESIA |
7 |
0.0002 |
| 290 |
EYELID OEDEMA |
2 |
0.0002 |
| 291 |
HYPOXIA |
6 |
0.0002 |
| 292 |
URINE ODOUR ABNORMAL |
1 |
0.0002 |
| 293 |
CATARACT |
10 |
0.0002 |
| 294 |
TYPE 1 DIABETES MELLITUS |
1 |
0.0002 |
| 295 |
LACRIMATION INCREASED |
5 |
0.0002 |
| 296 |
VISUAL IMPAIRMENT |
20 |
0.0002 |
| 297 |
SECRETION DISCHARGE |
2 |
0.0002 |
| 298 |
SWELLING OF EYELID |
1 |
0.0002 |
| 299 |
HERPES SIMPLEX |
1 |
0.0002 |
| 300 |
METASTASES TO LYMPH NODES |
1 |
0.0001 |
| 301 |
THROAT TIGHTNESS |
4 |
0.0001 |
| 302 |
ULCER HAEMORRHAGE |
1 |
0.0001 |
| 303 |
UVEITIS |
2 |
0.0001 |
| 304 |
ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD |
1 |
0.0001 |
| 305 |
LARGE INTESTINE POLYP |
1 |
0.0001 |
| 306 |
APPLICATION SITE REACTION |
1 |
0.0001 |
| 307 |
PAPULE |
1 |
0.0001 |
| 308 |
DUODENAL ULCER |
1 |
0.0001 |
| 309 |
SINUS TACHYCARDIA |
2 |
0.0001 |
| 310 |
IMPAIRED QUALITY OF LIFE |
2 |
0.0001 |
| 311 |
GRAFT VERSUS HOST DISEASE |
1 |
0.0001 |
| 312 |
SENSITIVE SKIN |
1 |
0.0001 |
| 313 |
BLOOD PRESSURE DIASTOLIC DECREASED |
1 |
0.0001 |
| 314 |
EYE SWELLING |
5 |
0.0001 |
| 315 |
HYDRONEPHROSIS |
1 |
0.0001 |
| 316 |
TROPONIN INCREASED |
1 |
0.0001 |
| 317 |
AORTIC ANEURYSM |
1 |
0.0001 |
| 318 |
PHARYNGEAL OEDEMA |
2 |
0.0001 |
| 319 |
ATRIOVENTRICULAR BLOCK |
1 |
0.0001 |
| 320 |
HAEMORRHAGIC STROKE |
1 |
0.0001 |
| 321 |
CYANOSIS |
2 |
0.0001 |
| 322 |
PRODUCT USE COMPLAINT |
2 |
0.0001 |
| 323 |
BLOOD ALBUMIN DECREASED |
1 |
0.0001 |
| 324 |
POST PROCEDURAL INFECTION |
1 |
0.0001 |
| 325 |
HYPERAESTHESIA |
1 |
0.0001 |
| 326 |
EOSINOPHIL COUNT INCREASED |
1 |
0.0001 |
| 327 |
EYE PRURITUS |
4 |
0.0001 |
| 328 |
PSEUDOMONAS INFECTION |
1 |
0.0001 |
| 329 |
RASH GENERALISED |
3 |
0.0001 |
| 330 |
PULMONARY OEDEMA |
5 |
0.0001 |
| 331 |
END STAGE RENAL DISEASE |
2 |
0.0001 |
| 332 |
DYSURIA |
4 |
0.0001 |
| 333 |
PRODUCT DISTRIBUTION ISSUE |
1 |
0.0001 |
| 334 |
NEPHROPATHY |
1 |
0.0001 |
| 335 |
TUBULOINTERSTITIAL NEPHRITIS |
2 |
0.0001 |
| 336 |
SQUAMOUS CELL CARCINOMA |
1 |
0.0001 |
| 337 |
SPINAL DISORDER |
1 |
0.0001 |
| 338 |
HYPERCHOLESTEROLAEMIA |
1 |
0.0001 |
| 339 |
BODY TEMPERATURE DECREASED |
1 |
0.0001 |
| 340 |
SPINAL FRACTURE |
2 |
0.0001 |
| 341 |
TOXIC SKIN ERUPTION |
1 |
0.0001 |
| 342 |
HYPOTHERMIA |
1 |
0.0001 |
| 343 |
SUBARACHNOID HAEMORRHAGE |
1 |
0.0001 |
| 344 |
TENDERNESS |
1 |
0.0001 |
| 345 |
POOR QUALITY PRODUCT ADMINISTERED |
1 |
0.0001 |
| 346 |
FULL BLOOD COUNT ABNORMAL |
1 |
0.0001 |
| 347 |
SKIN CANCER |
2 |
0.0001 |
| 348 |
LACTIC ACIDOSIS |
3 |
0.0001 |
| 349 |
IMPAIRED HEALING |
3 |
0.0001 |
| 350 |
WOUND INFECTION |
1 |
0.0001 |
| 351 |
ASPIRATION |
1 |
0.0001 |
| 352 |
BLOOD GLUCOSE FLUCTUATION |
1 |
0.0001 |
| 353 |
ANGIOEDEMA |
4 |
0.0001 |
| 354 |
RED BLOOD CELL SEDIMENTATION RATE INCREASED |
1 |
0.0001 |
| 355 |
EYE INFECTION |
1 |
0.0001 |
| 356 |
STATUS EPILEPTICUS |
1 |
0.0001 |
| 357 |
HAEMATURIA |
3 |
0.0001 |
| 358 |
CHOLECYSTECTOMY |
1 |
0.0001 |
| 359 |
MUSCLE TWITCHING |
2 |
0.0001 |
| 360 |
METASTASES TO LUNG |
1 |
0.0001 |
| 361 |
BACTERAEMIA |
1 |
0.0001 |
| 362 |
MYOCLONUS |
1 |
0.0001 |
| 363 |
MACULAR DEGENERATION |
1 |
0.0001 |
| 364 |
MUSCLE RIGIDITY |
1 |
0.0001 |
| 365 |
THYROID CANCER |
1 |
0.0001 |
| 366 |
NO THERAPEUTIC RESPONSE |
1 |
0.0001 |
| 367 |
DISCOMFORT |
5 |
0.0001 |
| 368 |
ENCEPHALOPATHY |
2 |
0.0001 |
| 369 |
APPLICATION SITE IRRITATION |
1 |
0.0001 |
| 370 |
DERMATITIS ALLERGIC |
1 |
0.0001 |
| 371 |
MYDRIASIS |
1 |
0.0001 |
| 372 |
SWELLING FACE |
5 |
0.0001 |
| 373 |
NODULE |
1 |
0.0001 |
| 374 |
BEDRIDDEN |
1 |
0.0001 |
| 375 |
RESPIRATORY ARREST |
2 |
0.0001 |
| 376 |
DEVICE OCCLUSION |
1 |
0.0001 |
| 377 |
SEIZURE |
8 |
0.0001 |
| 378 |
ANOSMIA |
1 |
0.0001 |
| 379 |
GASTROENTERITIS |
1 |
0.0001 |
| 380 |
DRUG WITHDRAWAL SYNDROME NEONATAL |
1 |
0.0001 |
| 381 |
COLON CANCER |
1 |
0.0001 |
| 382 |
APHASIA |
2 |
0.0001 |
| 383 |
OSTEOPENIA |
1 |
0.0001 |
| 384 |
CHRONIC KIDNEY DISEASE |
5 |
0.0001 |
| 385 |
TINNITUS |
3 |
0.0001 |
| 386 |
ANKLE FRACTURE |
1 |
0.0001 |
| 387 |
SWELLING |
6 |
0.0001 |
| 388 |
MENINGIOMA |
1 |
0.0001 |
| 389 |
SWOLLEN TONGUE |
2 |
0.0001 |
| 390 |
HEAD INJURY |
2 |
0.0001 |
| 391 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
1 |
0.0001 |
| 392 |
OBESITY |
1 |
0.0001 |
| 393 |
SCIATICA |
1 |
0.0001 |
| 394 |
HIP FRACTURE |
2 |
0.0001 |
| 395 |
DRY EYE |
3 |
0.0001 |
| 396 |
BLOOD UREA INCREASED |
1 |
0.0001 |
| 397 |
CELLULITIS |
3 |
0.0001 |
| 398 |
FACE OEDEMA |
1 |
0.0001 |
| 399 |
METASTASES TO LIVER |
1 |
0.0001 |
| 400 |
BLOOD TRIGLYCERIDES INCREASED |
1 |
0.0001 |
| 401 |
BRADYCARDIA |
3 |
0.0001 |
| 402 |
LYMPHADENOPATHY |
2 |
0.0001 |
| 403 |
DIABETES MELLITUS INADEQUATE CONTROL |
1 |
0.0001 |
| 404 |
OFF LABEL USE |
48 |
0.0001 |
| 405 |
HYPERSENSITIVITY |
10 |
0.0001 |
| 406 |
OXYGEN SATURATION DECREASED |
3 |
0.0001 |
| 407 |
DYSARTHRIA |
2 |
0.0001 |
| 408 |
BLOOD SODIUM DECREASED |
1 |
0.0001 |
| 409 |
RENAL FAILURE |
7 |
0.0001 |
| 410 |
MUSCULOSKELETAL DISORDER |
1 |
0.0001 |
| 411 |
SLEEP APNOEA SYNDROME |
1 |
0.0001 |
| 412 |
GLAUCOMA |
1 |
0.0001 |
| 413 |
EAR PAIN |
1 |
0.0001 |
| 414 |
BLOOD PRESSURE SYSTOLIC INCREASED |
1 |
0.0001 |
| 415 |
CYTOKINE RELEASE SYNDROME |
1 |
0.0000 |
| 416 |
BONE MARROW FAILURE |
1 |
0.0000 |
| 417 |
PRODUCT PREPARATION ERROR |
1 |
0.0000 |
| 418 |
CARDIAC ARREST |
4 |
0.0000 |
| 419 |
TOXICITY TO VARIOUS AGENTS |
8 |
0.0000 |
| 420 |
HALLUCINATION, VISUAL |
1 |
0.0000 |
| 421 |
RHINORRHOEA |
3 |
0.0000 |
| 422 |
PRODUCT DISPENSING ERROR |
1 |
0.0000 |
| 423 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
2 |
0.0000 |
| 424 |
SNEEZING |
1 |
0.0000 |
| 425 |
THERAPY NON-RESPONDER |
2 |
0.0000 |
| 426 |
CHROMATURIA |
1 |
0.0000 |
| 427 |
HEART RATE IRREGULAR |
1 |
0.0000 |
| 428 |
MUSCLE SPASMS |
8 |
0.0000 |
| 429 |
SHOCK |
1 |
0.0000 |
| 430 |
DYSPHAGIA |
4 |
0.0000 |
| 431 |
PULMONARY EMBOLISM |
4 |
0.0000 |
| 432 |
EMOTIONAL DISTRESS |
5 |
0.0000 |
| 433 |
MENTAL IMPAIRMENT |
1 |
0.0000 |
| 434 |
PRESYNCOPE |
1 |
0.0000 |
| 435 |
NEURALGIA |
1 |
0.0000 |
| 436 |
CEREBRAL INFARCTION |
1 |
0.0000 |
| 437 |
LUNG DISORDER |
2 |
0.0000 |
| 438 |
ABASIA |
1 |
0.0000 |
| 439 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
1 |
0.0000 |
| 440 |
AGEUSIA |
1 |
0.0000 |
| 441 |
HYPOAESTHESIA |
6 |
0.0000 |
| 442 |
HYPOTENSION |
8 |
0.0000 |
| 443 |
GLYCOSYLATED HAEMOGLOBIN INCREASED |
1 |
0.0000 |
| 444 |
ABDOMINAL PAIN LOWER |
1 |
0.0000 |
| 445 |
FLUSHING |
4 |
0.0000 |
| 446 |
FLUID RETENTION |
2 |
0.0000 |
| 447 |
ACUTE KIDNEY INJURY |
6 |
0.0000 |
| 448 |
HYPOPHAGIA |
1 |
0.0000 |
| 449 |
LOSS OF CONSCIOUSNESS |
5 |
0.0000 |
| 450 |
ERECTILE DYSFUNCTION |
1 |
0.0000 |
| 451 |
ERYTHEMA |
8 |
0.0000 |
| 452 |
HYPERHIDROSIS |
5 |
0.0000 |
| 453 |
DEAFNESS |
1 |
0.0000 |
| 454 |
ANHEDONIA |
1 |
0.0000 |
| 455 |
CARDIAC FAILURE |
3 |
0.0000 |
| 456 |
GASTROOESOPHAGEAL REFLUX DISEASE |
3 |
0.0000 |
| 457 |
FEAR |
1 |
0.0000 |
| 458 |
DRUG EFFECT DECREASED |
2 |
0.0000 |
| 459 |
OVERDOSE |
8 |
0.0000 |
| 460 |
BLOOD BILIRUBIN INCREASED |
1 |
0.0000 |
| 461 |
INFLUENZA LIKE ILLNESS |
3 |
0.0000 |
| 462 |
RESPIRATORY DISTRESS |
1 |
0.0000 |
| 463 |
ANAPHYLACTIC REACTION |
2 |
0.0000 |
| 464 |
HAEMOPTYSIS |
1 |
0.0000 |
| 465 |
URTICARIA |
6 |
0.0000 |
| 466 |
HYPONATRAEMIA |
2 |
0.0000 |
| 467 |
ANGINA PECTORIS |
1 |
0.0000 |
| 468 |
INTENTIONAL PRODUCT MISUSE |
3 |
0.0000 |
| 469 |
TACHYCARDIA |
3 |
0.0000 |
| 470 |
WHEEZING |
2 |
0.0000 |
| 471 |
BLOOD POTASSIUM DECREASED |
1 |
0.0000 |
| 472 |
ALANINE AMINOTRANSFERASE INCREASED |
2 |
0.0000 |
| 473 |
PRODUCT USE ISSUE |
6 |
0.0000 |
| 474 |
NEUROPATHY PERIPHERAL |
3 |
0.0000 |
| 475 |
HYPOTHYROIDISM |
1 |
0.0000 |
| 476 |
METABOLIC ACIDOSIS |
1 |
0.0000 |
| 477 |
MOVEMENT DISORDER |
1 |
0.0000 |
| 478 |
HEART RATE INCREASED |
3 |
0.0000 |
| 479 |
EXPIRED PRODUCT ADMINISTERED |
1 |
0.0000 |
| 480 |
SYNCOPE |
3 |
0.0000 |
| 481 |
GAIT INABILITY |
1 |
0.0000 |
| 482 |
TYPE 2 DIABETES MELLITUS |
1 |
0.0000 |
| 483 |
CHEST DISCOMFORT |
3 |
0.0000 |
| 484 |
DELIRIUM |
1 |
0.0000 |
| 485 |
HEADACHE |
18 |
0.0000 |
| 486 |
HAEMORRHAGE |
3 |
0.0000 |
| 487 |
PRURITUS |
11 |
0.0000 |
| 488 |
HEART RATE DECREASED |
1 |
0.0000 |
| 489 |
HYPERTENSION |
6 |
0.0000 |
| 490 |
INCORRECT ROUTE OF DRUG ADMINISTRATION |
1 |
0.0000 |
| 491 |
CEREBRAL HAEMORRHAGE |
1 |
0.0000 |
| 492 |
ELECTROCARDIOGRAM QT PROLONGED |
1 |
0.0000 |
| 493 |
DRUG EFFECT INCOMPLETE |
1 |
0.0000 |
| 494 |
PANIC ATTACK |
1 |
0.0000 |
| 495 |
RESTLESSNESS |
1 |
0.0000 |
| 496 |
AGITATION |
2 |
0.0000 |
| 497 |
EPISTAXIS |
2 |
0.0000 |
| 498 |
DYSPNOEA EXERTIONAL |
1 |
0.0000 |
| 499 |
MUSCULAR WEAKNESS |
3 |
0.0000 |
| 500 |
BLOOD PRESSURE INCREASED |
4 |
0.0000 |
| 501 |
PALPITATIONS |
3 |
0.0000 |
| 502 |
CHILLS |
3 |
0.0000 |
| 503 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
1 |
0.0000 |
| 504 |
DRUG INTERACTION |
4 |
0.0000 |
| 505 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
5 |
0.0000 |
| 506 |
OEDEMA PERIPHERAL |
3 |
0.0000 |
| 507 |
FOETAL EXPOSURE DURING PREGNANCY |
2 |
0.0000 |
| 508 |
ANXIETY |
7 |
0.0000 |
| 509 |
OSTEOPOROSIS |
1 |
0.0000 |
| 510 |
PRODUCT USE IN UNAPPROVED INDICATION |
6 |
0.0000 |
| 511 |
TREMOR |
4 |
0.0000 |
| 512 |
CARDIO-RESPIRATORY ARREST |
1 |
0.0000 |
| 513 |
HYPOACUSIS |
1 |
0.0000 |
| 514 |
BALANCE DISORDER |
2 |
0.0000 |
| 515 |
SEPTIC SHOCK |
1 |
0.0000 |
| 516 |
INSOMNIA |
6 |
0.0000 |
| 517 |
DEHYDRATION |
3 |
0.0000 |
| 518 |
PRODUCT QUALITY ISSUE |
3 |
0.0000 |
| 519 |
NO ADVERSE EVENT |
4 |
0.0000 |
| 520 |
LOWER RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 521 |
MEMORY IMPAIRMENT |
3 |
0.0000 |
| 522 |
SKIN IRRITATION |
1 |
0.0000 |
| 523 |
SKIN DISCOLOURATION |
1 |
0.0000 |
| 524 |
HYPOKALAEMIA |
1 |
0.0000 |
| 525 |
UPPER RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 526 |
BLOOD CHOLESTEROL INCREASED |
1 |
0.0000 |
| 527 |
BLOOD GLUCOSE INCREASED |
4 |
0.0000 |
| 528 |
ARRHYTHMIA |
1 |
0.0000 |
| 529 |
DISEASE RECURRENCE |
1 |
0.0000 |
| 530 |
MIGRAINE |
2 |
0.0000 |
| 531 |
RASH ERYTHEMATOUS |
1 |
0.0000 |
| 532 |
CONTUSION |
2 |
0.0000 |
| 533 |
INFECTION |
3 |
0.0000 |
| 534 |
DRUG INTOLERANCE |
2 |
0.0000 |
| 535 |
DYSPEPSIA |
2 |
0.0000 |
| 536 |
MALIGNANT NEOPLASM PROGRESSION |
2 |
0.0000 |
| 537 |
NERVOUSNESS |
1 |
0.0000 |
| 538 |
MUSCULOSKELETAL PAIN |
1 |
0.0000 |
| 539 |
SPEECH DISORDER |
1 |
0.0000 |
| 540 |
PANCREATITIS |
1 |
0.0000 |
| 541 |
ASPARTATE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 542 |
PLATELET COUNT DECREASED |
2 |
0.0000 |
| 543 |
DISTURBANCE IN ATTENTION |
1 |
0.0000 |
| 544 |
MEDICATION ERROR |
1 |
0.0000 |
| 545 |
PAIN |
11 |
0.0000 |
| 546 |
THROMBOCYTOPENIA |
2 |
0.0000 |
| 547 |
BLISTER |
1 |
0.0000 |
| 548 |
DEATH |
15 |
0.0000 |
| 549 |
PYREXIA |
6 |
0.0000 |
| 550 |
FATIGUE |
13 |
0.0000 |
| 551 |
FEELING ABNORMAL |
4 |
0.0000 |
| 552 |
PLEURAL EFFUSION |
1 |
0.0000 |
| 553 |
VERTIGO |
1 |
0.0000 |
| 554 |
FEELING HOT |
1 |
0.0000 |
| 555 |
CHEST PAIN |
3 |
0.0000 |
| 556 |
DIZZINESS |
8 |
0.0000 |
| 557 |
GAIT DISTURBANCE |
3 |
0.0000 |
| 558 |
FALL |
5 |
0.0000 |
| 559 |
SOMNOLENCE |
3 |
0.0000 |
| 560 |
MULTIPLE SCLEROSIS RELAPSE |
1 |
0.0000 |
| 561 |
BURNING SENSATION |
1 |
0.0000 |
| 562 |
INJURY |
1 |
0.0000 |
| 563 |
DYSPNOEA |
8 |
0.0000 |
| 564 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
1 |
0.0000 |
| 565 |
SKIN BURNING SENSATION |
1 |
0.0000 |
| 566 |
RESPIRATORY FAILURE |
1 |
0.0000 |
| 567 |
DYSGEUSIA |
1 |
0.0000 |
| 568 |
ASTHENIA |
5 |
0.0000 |
| 569 |
DIABETES MELLITUS |
1 |
0.0000 |
| 570 |
NAUSEA |
10 |
0.0000 |
| 571 |
INJECTION SITE HAEMORRHAGE |
1 |
0.0000 |
| 572 |
CONFUSIONAL STATE |
2 |
0.0000 |
| 573 |
DRY MOUTH |
1 |
0.0000 |
| 574 |
TREATMENT FAILURE |
1 |
0.0000 |
| 575 |
COMPLETED SUICIDE |
1 |
0.0000 |
| 576 |
RENAL IMPAIRMENT |
1 |
0.0000 |
| 577 |
CEREBROVASCULAR ACCIDENT |
2 |
0.0000 |
| 578 |
MYALGIA |
2 |
0.0000 |
| 579 |
INTENTIONAL PRODUCT USE ISSUE |
1 |
0.0000 |
| 580 |
MATERNAL EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 581 |
GASTROINTESTINAL DISORDER |
1 |
0.0000 |
| 582 |
ADVERSE DRUG REACTION |
1 |
0.0000 |
| 583 |
NASOPHARYNGITIS |
2 |
0.0000 |
| 584 |
CARDIAC DISORDER |
1 |
0.0000 |
| 585 |
ALOPECIA |
2 |
0.0000 |
| 586 |
PAIN IN EXTREMITY |
3 |
0.0000 |
| 587 |
SINUSITIS |
1 |
0.0000 |
| 588 |
ACCIDENTAL EXPOSURE TO PRODUCT |
1 |
0.0000 |
| 589 |
DIARRHOEA |
6 |
0.0000 |
| 590 |
PNEUMONIA |
3 |
0.0000 |
| 591 |
WHITE BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 592 |
RASH |
4 |
0.0000 |
| 593 |
SEPSIS |
1 |
0.0000 |
| 594 |
ASTHMA |
1 |
0.0000 |
| 595 |
VOMITING |
4 |
0.0000 |
| 596 |
JOINT SWELLING |
1 |
0.0000 |
| 597 |
PSORIASIS |
1 |
0.0000 |
| 598 |
NEUTROPENIA |
1 |
0.0000 |
| 599 |
WEIGHT DECREASED |
2 |
0.0000 |
| 600 |
MALAISE |
3 |
0.0000 |
| 601 |
DRUG INEFFECTIVE |
9 |
0.0000 |
| 602 |
CONDITION AGGRAVATED |
2 |
0.0000 |
| 603 |
ABDOMINAL DISCOMFORT |
1 |
0.0000 |
| 604 |
URINARY TRACT INFECTION |
1 |
0.0000 |
| 605 |
MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 606 |
COVID-19 |
1 |
0.0000 |
| 607 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
1 |
0.0000 |
| 608 |
ARTHRALGIA |
2 |
0.0000 |
| 609 |
CONSTIPATION |
1 |
0.0000 |
| 610 |
WEIGHT INCREASED |
1 |
0.0000 |
| 611 |
DEPRESSION |
1 |
0.0000 |
| 612 |
INCORRECT DOSE ADMINISTERED |
1 |
0.0000 |
| 613 |
DECREASED APPETITE |
1 |
0.0000 |
| 614 |
BACK PAIN |
1 |
0.0000 |
| 615 |
COUGH |
1 |
0.0000 |
| 616 |
PRODUCT DOSE OMISSION ISSUE |
1 |
0.0000 |
| 617 |
INJECTION SITE PAIN |
1 |
0.0000 |